124 related articles for article (PubMed ID: 34129933)
1. Combining gene expression signature with clinical features for survival stratification of gastric cancer.
Sun Q; Guo D; Li S; Xu Y; Jiang M; Li Y; Duan H; Zhuo W; Liu W; Zhu S; Wang L; Zhou T
Genomics; 2021 Jul; 113(4):2683-2694. PubMed ID: 34129933
[TBL] [Abstract][Full Text] [Related]
2. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
Ma B; Li Y; Ren Y
Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
[TBL] [Abstract][Full Text] [Related]
3. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
Liu J; Lu J; Li W
Front Immunol; 2021; 12():738068. PubMed ID: 34630418
[TBL] [Abstract][Full Text] [Related]
4. A 16-mRNA signature optimizes recurrence-free survival prediction of Stages II and III gastric cancer.
Peng K; Chen E; Li W; Cheng X; Yu Y; Cui Y; Li Q; Wang Y; Xu X; Tang C; Gan L; Yu S; Liu T
J Cell Physiol; 2020 Jul; 235(7-8):5777-5786. PubMed ID: 32048287
[TBL] [Abstract][Full Text] [Related]
5. Establishing a cancer driver gene signature-based risk model for predicting the prognoses of gastric cancer patients.
Chen J; Zhou C; Liu Y
Aging (Albany NY); 2022 Mar; 14(5):2383-2399. PubMed ID: 35288483
[TBL] [Abstract][Full Text] [Related]
6. Construction and Validation of a Novel Prognostic Signature for Intestinal Type of Gastric Cancer.
Zhang F; Maswikiti EP; Wei Y; Wu W; Li Y
Dis Markers; 2021; 2021():5567392. PubMed ID: 34422135
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
[No Abstract] [Full Text] [Related]
8. Comprehensive analysis of a 14 immune-related gene pair signature to predict the prognosis and immune features of gastric cancer.
Liu C; Chen B; Huang Z; Hu C; Jiang L; Zhao C
Int Immunopharmacol; 2020 Dec; 89(Pt B):107074. PubMed ID: 33049494
[TBL] [Abstract][Full Text] [Related]
9. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes.
Bai Y; Wei C; Zhong Y; Zhang Y; Long J; Huang S; Xie F; Tian Y; Wang X; Zhao H
Int J Biol Sci; 2020; 16(7):1153-1165. PubMed ID: 32174791
[No Abstract] [Full Text] [Related]
11. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer.
Nie K; Deng Z; Zheng Z; Wen Y; Pan J; Jiang X; Yan Y; Liu P; Liu F; Li P
DNA Cell Biol; 2020 Sep; 39(9):1532-1544. PubMed ID: 32644844
[TBL] [Abstract][Full Text] [Related]
12. Identification of a seven-cell cycle signature predicting overall survival for gastric cancer.
Zhang LQ; Zhou SL; Li JK; Chen PN; Zhao XK; Wang LD; Li XL; Zhou FY
Aging (Albany NY); 2022 May; 14(9):3989-3999. PubMed ID: 35537781
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide identification of a novel miRNA-based signature to predict recurrence in patients with gastric cancer.
Yang Y; Qu A; Zhao R; Hua M; Zhang X; Dong Z; Zheng G; Pan H; Wang H; Yang X; Zhang Y
Mol Oncol; 2018 Dec; 12(12):2072-2084. PubMed ID: 30242969
[TBL] [Abstract][Full Text] [Related]
14. A transcriptomic study for identifying cardia- and non-cardia-specific gastric cancer prognostic factors using genetic algorithm-based methods.
Xin J; Wu Y; Wang X; Li S; Chu H; Wang M; Du M; Zhang Z
J Cell Mol Med; 2020 Aug; 24(16):9457-9465. PubMed ID: 32649057
[TBL] [Abstract][Full Text] [Related]
15. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.
Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X
Front Immunol; 2021; 12():651033. PubMed ID: 34054812
[TBL] [Abstract][Full Text] [Related]
16. A nine-consensus-prognostic -gene-based prognostic signature, recognizing the dichotomized subgroups of gastric cancer patients with different clinical outcomes and therapeutic strategies.
Ji D; Yang Y; Zhou F; Li C
Front Genet; 2022; 13():909175. PubMed ID: 36226177
[No Abstract] [Full Text] [Related]
17. Bayesian hierarchical lasso Cox model: A 9-gene prognostic signature for overall survival in gastric cancer in an Asian population.
Chu J; Sun N; Hu W; Chen X; Yi N; Shen Y
PLoS One; 2022; 17(4):e0266805. PubMed ID: 35421138
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of a Robust Immune-Related Prognostic Signature for Gastric Cancer.
Huo J; Wu L; Zang Y
J Immunol Res; 2021; 2021():5554342. PubMed ID: 34007851
[TBL] [Abstract][Full Text] [Related]
20. Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer.
Che K; Liu F; Wu N; Liu Q; Yuan L; Wei J
Cancer Med; 2020 Oct; 9(19):7137-7150. PubMed ID: 32810384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]